1
|
Swetha M, Keerthana CK, Rayginia TP, Nath LR, Haritha NH, Shabna A, Kalimuthu K, Thangarasu AK, Aiswarya SU, Jannet S, Pillai S, Harikumar KB, Sundaram S, Anto NP, Wu DH, Lankalapalli RS, Towner R, Isakov N, Deepa SS, Anto RJ. Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma. Pharmaceuticals (Basel) 2022; 15:ph15050636. [PMID: 35631464 PMCID: PMC9143354 DOI: 10.3390/ph15050636] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2022] [Revised: 04/21/2022] [Accepted: 04/30/2022] [Indexed: 12/03/2022] Open
Abstract
We previously reported the remarkable potency of uttroside B (Utt-B), saponin-isolated and characterized in our lab from Solanum nigrum Linn, against HCC. Recently, the U.S. FDA approved Utt-B as an ‘orphan drug’ against HCC. The current study validates the superior anti-HCC efficacy of Utt-B over sorafenib, the first-line treatment option against HCC. The therapeutic efficacies of Utt-B vs. sorafenib against HCC were compared in vitro, using various liver cancer cell lines and in vivo, utilizing NOD.CB17-Prkdcscid/J mice bearing human HCC xenografts. Our data indicate that Utt-B holds an augmented anti-HCC efficacy over sorafenib. Our previous report demonstrated the pharmacological safety of Utt-B in Chang Liver, the normal immortalized hepatocytes, and in the acute and chronic toxicity murine models even at elevated Utt-B concentrations. Here, we show that higher concentrations of sorafenib induce severe toxicity, in Chang Liver, as well as in acute and chronic in vivo models, indicating that, apart from the superior therapeutic benefit over sorafenib, Utt-B is a pharmacologically safer molecule, and the drug-induced undesirable effects can, thus, be substantially alleviated in the context of HCC chemotherapy. Clinical studies in HCC patients utilizing Utt-B, is a contiguous key step to promote this drug to the clinic.
Collapse
Affiliation(s)
- Mundanattu Swetha
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, Kerala, India; (M.S.); (C.K.K.); (T.P.R.); (L.R.N.); (N.H.H.); (A.S.); (K.K.); (S.U.A.); (S.J.); (K.B.H.)
- Department of Biotechnology, University of Kerala, Thiruvananthapuram 695011, Kerala, India
| | - Chenicheri K. Keerthana
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, Kerala, India; (M.S.); (C.K.K.); (T.P.R.); (L.R.N.); (N.H.H.); (A.S.); (K.K.); (S.U.A.); (S.J.); (K.B.H.)
- Department of Biotechnology, University of Kerala, Thiruvananthapuram 695011, Kerala, India
| | - Tennyson P. Rayginia
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, Kerala, India; (M.S.); (C.K.K.); (T.P.R.); (L.R.N.); (N.H.H.); (A.S.); (K.K.); (S.U.A.); (S.J.); (K.B.H.)
- Department of Biotechnology, University of Kerala, Thiruvananthapuram 695011, Kerala, India
| | - Lekshmi R. Nath
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, Kerala, India; (M.S.); (C.K.K.); (T.P.R.); (L.R.N.); (N.H.H.); (A.S.); (K.K.); (S.U.A.); (S.J.); (K.B.H.)
- Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Kochi 682041, Kerala, India
| | - Nair Hariprasad Haritha
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, Kerala, India; (M.S.); (C.K.K.); (T.P.R.); (L.R.N.); (N.H.H.); (A.S.); (K.K.); (S.U.A.); (S.J.); (K.B.H.)
| | - Anwar Shabna
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, Kerala, India; (M.S.); (C.K.K.); (T.P.R.); (L.R.N.); (N.H.H.); (A.S.); (K.K.); (S.U.A.); (S.J.); (K.B.H.)
| | - Kalishwaralal Kalimuthu
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, Kerala, India; (M.S.); (C.K.K.); (T.P.R.); (L.R.N.); (N.H.H.); (A.S.); (K.K.); (S.U.A.); (S.J.); (K.B.H.)
| | - Arun K. Thangarasu
- Chemical Sciences and Technology Division, CSIR-National Institute for Interdisciplinary Science and Technology, Thiruvananthapuram 695019, Kerala, India; (A.K.T.); (R.S.L.)
| | - Sreekumar U. Aiswarya
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, Kerala, India; (M.S.); (C.K.K.); (T.P.R.); (L.R.N.); (N.H.H.); (A.S.); (K.K.); (S.U.A.); (S.J.); (K.B.H.)
| | - Somaraj Jannet
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, Kerala, India; (M.S.); (C.K.K.); (T.P.R.); (L.R.N.); (N.H.H.); (A.S.); (K.K.); (S.U.A.); (S.J.); (K.B.H.)
| | - Sreekumar Pillai
- Department of Surgical Oncology, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India;
| | - Kuzhuvelil B. Harikumar
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, Kerala, India; (M.S.); (C.K.K.); (T.P.R.); (L.R.N.); (N.H.H.); (A.S.); (K.K.); (S.U.A.); (S.J.); (K.B.H.)
| | - Sankar Sundaram
- Department of Pathology, Government Medical College, Kottayam 686008, Kerala, India;
| | - Nikhil Ponnoor Anto
- The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, P.O. Box 653, Beer Sheva 84105, Israel; (N.P.A.); (N.I.)
| | - Dee H. Wu
- Section of Medical Physics, Department of Radiological Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA;
- School of Computer Science, Gallogly College of Engineering, University of Oklahoma, Norman, OK 731019, USA
- School of Electrical and Computer Engineering, Gallogly College of Engineering, University of Oklahoma, Norman, OK 731019, USA
| | - Ravi S. Lankalapalli
- Chemical Sciences and Technology Division, CSIR-National Institute for Interdisciplinary Science and Technology, Thiruvananthapuram 695019, Kerala, India; (A.K.T.); (R.S.L.)
| | - Rheal Towner
- Departments of Pathology and Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA;
| | - Noah Isakov
- The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, P.O. Box 653, Beer Sheva 84105, Israel; (N.P.A.); (N.I.)
| | - Sathyaseelan S. Deepa
- Department of Biochemistry and Molecular Biology, and Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA;
| | - Ruby John Anto
- Division of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, Kerala, India; (M.S.); (C.K.K.); (T.P.R.); (L.R.N.); (N.H.H.); (A.S.); (K.K.); (S.U.A.); (S.J.); (K.B.H.)
- Correspondence: ; Tel.: +91-471-2529473; Fax: +91-471-2348096
| |
Collapse
|
2
|
Nawaz A, Jamal A, Arif A, Parveen Z. In vitro cytotoxic potential of Solanum nigrum against human cancer cell lines. Saudi J Biol Sci 2021; 28:4786-4792. [PMID: 34354467 PMCID: PMC8324988 DOI: 10.1016/j.sjbs.2021.05.004] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2021] [Revised: 05/01/2021] [Accepted: 05/02/2021] [Indexed: 02/07/2023] Open
Abstract
Plants have natural products which use to possess antiproliferative potential against many cancers. In the present study, six isolated fractions (ethyl acetate, petroleum ether, chloroform, n-butanol, ethanol and aqueous) from Solanum nigrum were evaluated for their cytotoxic effect on different cell lines. Hepatic carcinoma cell line (HepG2), cervical cancer cell line (HeLa) and baby hamster kidney (BHK) used as normal non-cancerous cells were evaluated for cytotoxicity against isolated fractions. Cell viability assay was performed to evaluate the cytotoxicity of all fractions on different cell lines followed by the lactate dehydrogenase and vascular endothelial growth factor assays of most active fraction among all screened for cytotoxic analysis. HPLC analysis of most active fractions against cytotoxicity was performed to check the biological activity of compounds. Results displayed the potent cytotoxic activity of ethyl acetate fraction of S. nigrum against HepG2 cells with IC50 value of 7.89 μg/ml. Other fractions exhibited potent anticancer activity against HepG2 cells followed by HeLa cells. Fractions in our study showed no cytotoxicity in BHK cells. Cytotoxic activity observed in our current study exposed high antiproliferative potential and activity of ethyl acetate fraction against HepG2 cells. The results demonstrated that S. nigrum fractions exhibited anticancer activity against hepatic and cervical cancer cell lines with non-toxic effect in normal cells. These results reveal significant potential of S. nigrum for the therapeutic of cancers across the globe in future.
Collapse
Affiliation(s)
- Aisha Nawaz
- University of Central Punjab, Lahore, Pakistan
| | - Adil Jamal
- Sciences and Research, College of Nursing, Umm Al-Qura University, Makkah 715, Saudi Arabia
| | - Amina Arif
- University of Central Punjab, Lahore, Pakistan
| | - Zahida Parveen
- Pakistan Council of Scientific and Industrial Research, Lahore, Pakistan
| |
Collapse
|
3
|
Li JH, Li SY, Shen MX, Qiu RZ, Fan HW, Li YB. Anti-tumor effects of Solanum nigrum L. extraction on C6 high-grade glioma. J Ethnopharmacol 2021; 274:114034. [PMID: 33746002 DOI: 10.1016/j.jep.2021.114034] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/24/2021] [Revised: 03/07/2021] [Accepted: 03/12/2021] [Indexed: 06/12/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Solanum nigrum L. (SN) is a traditional Chinese medicine with anti-tumor effects, has been used in cancer for centuries, but the role on high-grade gliomas (HGG) is not clear. AIM OF THE STUDY This work was to investigate the anti-tumor effects of SN extract on rat C6 glioma in vitro and in vivo, providing a new medium for the treatment of HGG. MATERIALS AND METHODS After identification and quality inspection of SN medicinal materials by HPLC-MS/MS and HPLC, CCK8 and colony formation assay were conducted to study the effects of SN on vitality and proliferation of C6 cells. Cell morphology was evaluated by HE staining, and flow cytometry was used for apoptosis analysis. The effects on cell migration and invasion were determined by transwell and wound healing assay. Western blot was used to further investigate the influence of SN on migration, invasion and apoptosis of tumor cells. In addition, the rat intracranial transplanted tumor model was used to evaluate the effects of SN on growth and infiltration of tumor and proliferation of transplanted tumor cells. RESULTS SN extract suppressed the viability of C6 cells in a dose-dependent manner. The extract attenuated cell cloning, migration and invasion, and induced cell Annexin V+ PI+ late-stage apoptosis. Besides, SN induced the expression of apoptotic proteins including Bax and Cleaved Caspase-3, downregulated anti-apoptotic protein Bcl-2, and decreased the level of migratory proteins MMP-2 and MMP-9. Moreover, SN reduced the growth and infiltration of C6 glioma tissue and suppressed the proliferation of tumor cells in rat brain. CONCLUSIONS SN extract has significant inhibitory activity on the growth and invasion of C6 HGG in vivo and in vitro.
Collapse
Affiliation(s)
- Jia-Hui Li
- Department of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210006, China
| | - Song-Ya Li
- Department of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210006, China
| | - Ming-Xue Shen
- Department of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210006, China
| | - Run-Ze Qiu
- Department of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210006, China
| | - Hong-Wei Fan
- Department of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210006, China.
| | - Ying-Bin Li
- Department of Neurosurgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210011, China.
| |
Collapse
|
4
|
Liang MK, Liang XQ, Zhong J, Wei YT, Lian ZP, Huang ZK, Liang J. Integrative analysis of epigenomics, transcriptomics, and proteomics to identify key targets and pathways of Weining granule for gastric cancer. J Ethnopharmacol 2021; 270:113787. [PMID: 33422657 DOI: 10.1016/j.jep.2021.113787] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/04/2020] [Revised: 12/26/2020] [Accepted: 01/03/2021] [Indexed: 06/12/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Weining granule (WNG) is a "Qi-Enriching and Kidney-Tonifying, Spleen-Reinforcing and Stasis-Removing" formula for gastric cancer (GC). Past research we noted WNG inhibited cell growth and raised apoptosis in GC. However, the underlying mechanism of WNG for GC have yet to be systematically clarified. AIM OF THE STUDY We sought to characterize the molecular landscape of GC cells in vitro after WNG treated, to identify the molecular targets and pathways that were associated with WNG for inducing the apoptosis of GC cells, and further to clarify underlying molecular mechanism of WNG for GC. MATERIALS AND METHODS We performed the techniques of RNA sequencing, tandem mass tags (TMT) based quantitative proteomics, and reduced representation bisulfite sequencing (RRBS) in WNG-treated/or untreated SGC-7901 GC cells to gain a comprehensive molecular portrait of WNG treatment. Then we integrated methylomics, transcriptomics, and proteomics data to carry out the bioinformatics analysis, and constructed the protein-protein interaction (PPI) network to identify molecular targets, and to discover the underlying signaling pathways associated with WNG for GC by network analysis. Besides, we verified the candidate target genes by Kaplan-Meier plotter database. RESULTS We identified 1249 significant differentially expressed genes (DEGs) from RNA expression datasets, 191 significant differentially abunabundant proteins (DAPs) from proteomics datasets, and 8293 significant differentially methylated regions (DMRs) from DNA methylation datasets. GO and KEGG analysis showed DEGs, DAPs, and DMRs enriched in the cancer-related biological processes of calcium signaling pathway, pathways in cancer, metabolic pathways, MAPK signaling pathway, PI3K-Akt signaling pathway, and transcriptional misregulation in cancer. We integrated three profile datasets and performed network analysis to distinguish the hub genes, and finally the genes of SOD2, HMOX1, MMP1, SRXN1, NOTCH1, MAPK14, TXNIP, VEGFA, POLR2F, and HSPA9 were identified. The Kaplan-Meier plotter confirmed that SOD2, MMP1, SRXN1, NOTCH1, MAPK14, TXNIP, VEGFA, and HSPA9 were significantly correlated with OS in GC patients (P < 0.01), while HMOX1 and POLR2F expression were not significantly relevant to survival of GC patients (P > 0.01). CONCLUSIONS SOD2, MMP1, SRXN1, NOTCH1, MAPK14, TXNIP, VEGFA, and HSPA9 were the predictive pharmaceutical targets of WNG for GC. The anticancer function of WNG was significantly associated with the pathways of focal adhesion pathway, PI3K-Akt signaling pathway, MAPK signaling pathway, and Wnt signaling pathway.
Collapse
Affiliation(s)
- Ming-Kun Liang
- Integrative Medicine Institute, Hunan University of Chinese Medicine, Changsha, 410208, China; Department of Science and Technology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, 541100, China
| | - Xing-Qiu Liang
- Medical College, Guangxi University, Nanning, 530004, China; Department of Science and Technology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, 541100, China
| | - Jing Zhong
- School of Basic Medical Sciences, Guangxi University of Chinese Medicine, Nanning, 530200, China
| | - Yu-Ting Wei
- School of Basic Medical Sciences, Guangxi University of Chinese Medicine, Nanning, 530200, China
| | - Zu-Ping Lian
- Department of Science and Technology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, 541100, China
| | - Zheng-Kai Huang
- Integrative Medicine Institute, Hunan University of Chinese Medicine, Changsha, 410208, China
| | - Jian Liang
- Medical College, Guangxi University, Nanning, 530004, China.
| |
Collapse
|
5
|
Abstract
CONTEXT Naringin is a natural flavanone glycoside that is found in the Chinese herbal medicines and citrus fruits. Studies have demonstrated that naringin possesses numerous biological and pharmacological properties, but few reviews of these studies have been performed. OBJECTIVE The present review gathers the fragmented information available in the literature describing the extraction of naringin, its pharmacology and its controlled release formulations. Current research progress and the therapeutic potential of naringin are also discussed. METHODS A literature survey for relevant information regarding the biological and pharmacological properties of naringin was conducted using Pubmed, Sciencedirect, MEDLINE, Springerlink and Google Scholar electronic databases from the year 2007-2015. RESULTS Naringin modulates signalling pathways and interacts with signalling molecules and thus has a wide range of pharmacological activities, including anti-inflammatory, anti-cancer activities, as well as effects on bone regeneration, metabolic syndrome, oxidative stress, genetic damage and central nervous system (CNS) diseases. Information was gathered that showed the extraction of naringin can be improved using several modifications. There has been some progress in the development of controlled release formulations of naringin. CONCLUSION Naringin is a promising candidate for further in vivo studies and clinical use. More detailed studies regarding its mechanism of action are required.
Collapse
Affiliation(s)
- Rui Chen
- a Medical Faculty , Kunming University of Science and Technology , Kunming , Yunnan Province , China
- b The First People's Hospital of Yunnan Province , Kunming , Yunnan Province , China
- c Affiliated Hospital of Kunming University of Science and Technology , Kunming , Yunnan Province , China
| | - Qiao-Ling Qi
- d Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D , Dali University , Dali , Yunnan Province , China
| | - Meng-Ting Wang
- a Medical Faculty , Kunming University of Science and Technology , Kunming , Yunnan Province , China
- b The First People's Hospital of Yunnan Province , Kunming , Yunnan Province , China
- c Affiliated Hospital of Kunming University of Science and Technology , Kunming , Yunnan Province , China
| | - Qi-Yan Li
- a Medical Faculty , Kunming University of Science and Technology , Kunming , Yunnan Province , China
- b The First People's Hospital of Yunnan Province , Kunming , Yunnan Province , China
- c Affiliated Hospital of Kunming University of Science and Technology , Kunming , Yunnan Province , China
| |
Collapse
|
6
|
Li W, Sun X, Liu B, Zhang L, Fan Z, Ji Y. Screening and identification of hepatotoxic component inEvodia rutaecarpabased on spectrum-effect relationship and UPLC-Q-TOFMS. Biomed Chromatogr 2016; 30:1975-1983. [DOI: 10.1002/bmc.3774] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2016] [Revised: 05/17/2016] [Accepted: 05/25/2016] [Indexed: 12/12/2022]
Affiliation(s)
- Wenlan Li
- College of Pharmacy; Harbin University of Commerce; Harbin 150076 People's Republic of China
| | - Xiangming Sun
- Research Center on Life Sciences and Environmental Sciences; Harbin University of Commerce; Harbin 150076 People's Republic of China
| | - Bingmei Liu
- Heilongjiang Provincial Hospital; Harbin 150001 People's Republic of China
| | - Lihui Zhang
- Research Center on Life Sciences and Environmental Sciences; Harbin University of Commerce; Harbin 150076 People's Republic of China
| | - Ziquan Fan
- Waters (Shanghai) Co., LTD; Shanghai 201206 People's Republic of China
| | - Yubin Ji
- Research Center on Life Sciences and Environmental Sciences; Harbin University of Commerce; Harbin 150076 People's Republic of China
| |
Collapse
|
7
|
Chu H, Wu T, Wu W, Tu W, Jiang S, Chen S, Ma Y, Liu Q, Zhou X, Jin L, Wang J. Involvement of collagen-binding heat shock protein 47 in scleroderma-associated fibrosis. Protein Cell 2015; 6:589-598. [PMID: 26091621 PMCID: PMC4506285 DOI: 10.1007/s13238-015-0171-3] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2015] [Accepted: 04/27/2015] [Indexed: 02/03/2023] Open
Abstract
Uncontrolled fibrosis of skin and internal organs is the main characteristic of scleroderma, and collagen is a major extracellular matrix protein that deposits in the fibrotic organs. As the chaperone of collagen, heat shock protein 47 (HSP47) is closely related with the development of fibrosis. To explore the potential function of HSP47 in the pathogenesis of scleroderma, the clinical, in vivo and in vitro studies were performed. In clinical, the increased mRNA level of HSP47 was observed in the skin fibroblasts and PBMC from scleroderma patients, and the enhanced protein level of HSP47 was also detected in the skin biopsy and plasma of the above patients. Unexpectedly, the enhanced levels of HSP47 were positively correlated with the presence of anti-centromere antibody in scleroderma patients. Moreover, a high expression of HSP47 was found in the skin lesion of BLM-induced scleroderma mouse model. Further in vitro studies demonstrated that HSP47 knockdown could block the intracellular and extracellular collagen over-productions induced by exogenous TGF-β. Therefore, the results in this study provide direct evidence that HSP47 is involved in the pathogenesis of scleroderma. The high expression of HSP47 can be detected in the circulatory system of scleroderma patients, indicating that HSP47 may become a pathological marker to assess the progression of scleroderma, and also explain the systemic fibrosis of scleroderma. Meanwhile, collagen over-expression is blocked by HSP47 knockdown, suggesting the possibility that HSP47 can be a potential therapeutic target for scleroderma.
Collapse
Affiliation(s)
- Haiyan Chu
- />Ministry of Education Key Laboratory of Contemporary Anthropology and State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200438 China
| | - Ting Wu
- />Ministry of Education Key Laboratory of Contemporary Anthropology and State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200438 China
| | - Wenyu Wu
- />Division of Dermatology, Huashan Hospital, Fudan University, Shanghai, 200040 China
- />Institute of Rheumatology, Immunology and Allergy, Fudan University, Shanghai, 20080 China
| | - Wenzhen Tu
- />Division of Rheumatology, Shanghai TCM-Integrated Hospital, Shanghai, 200082 China
| | - Shuai Jiang
- />Ministry of Education Key Laboratory of Contemporary Anthropology and State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200438 China
| | - Sidi Chen
- />Ministry of Education Key Laboratory of Contemporary Anthropology and State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200438 China
| | - Yanyun Ma
- />Ministry of Education Key Laboratory of Contemporary Anthropology and State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200438 China
| | - Qingmei Liu
- />Ministry of Education Key Laboratory of Contemporary Anthropology and State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200438 China
| | - Xiaodong Zhou
- />Division of Rheumatology, University of Texas Health Science Center at Houston, Houston, TX 77030 USA
| | - Li Jin
- />Ministry of Education Key Laboratory of Contemporary Anthropology and State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200438 China
| | - Jiucun Wang
- />Ministry of Education Key Laboratory of Contemporary Anthropology and State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200438 China
- />Institute of Rheumatology, Immunology and Allergy, Fudan University, Shanghai, 20080 China
| |
Collapse
|
8
|
Zhang Y, Li F, Huang F, Xie G, Wei R, Chen T, Liu J, Zhao A, Jia W. Metabolomics analysis reveals variation inSchisandra chinensismetabolites from different origins. J Sep Sci 2014; 37:731-7. [PMID: 24415683 DOI: 10.1002/jssc.201301242] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2013] [Revised: 12/08/2013] [Accepted: 12/22/2013] [Indexed: 11/07/2022]
Affiliation(s)
- Yinan Zhang
- Center for Translational Medicine; Shanghai Key Laboratory of Diabetes Mellitus; Department of Endocrinology and Metabolism; Shanghai Jiao Tong University Affiliated Sixth People's Hospital; Shanghai P.R. China
| | - Fen Li
- School of Pharmacy; Shanghai Jiao Tong University; Shanghai China
| | - Fengjie Huang
- School of Pharmacy; Shanghai Jiao Tong University; Shanghai China
| | - Guoxiang Xie
- University of Hawaii Cancer Center; Honolulu HI USA
| | - Runmin Wei
- School of Pharmacy; Shanghai Jiao Tong University; Shanghai China
| | - Tianlu Chen
- Center for Translational Medicine; Shanghai Key Laboratory of Diabetes Mellitus; Department of Endocrinology and Metabolism; Shanghai Jiao Tong University Affiliated Sixth People's Hospital; Shanghai P.R. China
| | - Jiajian Liu
- Center for Translational Medicine; Shanghai Key Laboratory of Diabetes Mellitus; Department of Endocrinology and Metabolism; Shanghai Jiao Tong University Affiliated Sixth People's Hospital; Shanghai P.R. China
| | - Aihua Zhao
- Center for Translational Medicine; Shanghai Key Laboratory of Diabetes Mellitus; Department of Endocrinology and Metabolism; Shanghai Jiao Tong University Affiliated Sixth People's Hospital; Shanghai P.R. China
| | - Wei Jia
- Center for Translational Medicine; Shanghai Key Laboratory of Diabetes Mellitus; Department of Endocrinology and Metabolism; Shanghai Jiao Tong University Affiliated Sixth People's Hospital; Shanghai P.R. China
- University of Hawaii Cancer Center; Honolulu HI USA
| |
Collapse
|